Active ingredientPamidronic AcidCat. No. P-P011-001CAS 40391-99-9Family · Pharmaceutical analytical standards
Pamidronic Acid
A nitrogen-containing bisphosphonate given by intravenous infusion: patented in 1971 and approved for medical use in 1987, it is used for high blood calcium, Paget's disease of bone and to protect bone in cancers such as multiple myeloma. This family brings together the active ingredient and other impurities.
Did you know?It has also been used experimentally in osteogenesis imperfecta, the genetic condition known as 'brittle bone disease'.
Go to the active ingredient →Active ingredientPamidronic AcidCat. No. P-P011-001CAS 40391-99-9
Impurity3-Aminopropanoic AcidCat. No. P-P011-002CAS 107-95-9
Active ingredientDisodium PamidronateCat. No. P-P011-003CAS 57248-88-1
Active ingredientPamidronate disodium pentahydrateCat. No. P-P011-004CAS 109552-15-0No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substancePamidronate disodium pentahydrate CRSEDQM code Y0000524Family Pamidronic AcidNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.